Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.ConvaTec, a developer of medical technologies for community and hospital care, has signed a long-term global exclusive licensing agreement with Boehringer Technologies to market and distribute Boehringer's Engenex negative pressure wound therapy system incorporating Bio-Dome interface technology.
Subscribe to our email newsletter
Under the terms of the development and licensing agreement ConvaTec receives exclusive global marketing and distribution rights for the Engenex negative pressure wound therapy (NPWT) system. In addition, Boehringer Wound Systems will provide ongoing manufacturing support for many components of the system, and there will be ongoing co-development between Boehringer and ConvaTec for future enhancements to this and other technologies.
Boehringer’s NPWT system is an innovative technology and engineering solution that utilizes the application of negative pressure to a wound to promote healing by creating controlled tissue strain and removing excess fluid, including wound exudate.
David Johnson, CEO of ConvaTec, said: “This agreement is further evidence of ConvaTec’s commitment to expand our offerings for treating acute and chronic wounds. Negative pressure wound therapy is one of the largest and fastest growing market segments in wound management and we are thrilled to be partnering with Boehringer to help bring advanced solutions to our customers worldwide.”